Gabrielle Field

Gabrielle leverages her background in neuroscience to provide grounded, actionable advice on a wide variety of U.S. Food and Drug Administration (FDA) programs. She has experience working with startups and established companies alike on 510(k) premarket notifications, De Novo requests, Premarket Approval applications, Investigational Device Exemption submissions, Humanitarian Device Exemption applications, Pre-Submission meetings, Breakthrough Device designations, Total Product Life Cycle Advisory Program (TAP) requests, FDA Warning Letter responses, 483 Inspectional Observation responses, and advertising/promotional material development.

During law school, Gabrielle practiced housing law as a student attorney in the Health Justice Alliance Law Clinic. She was also elected president of the Health Law Society, taught legal research and writing as a law fellow, and served as an editor of the Georgetown Journal of Gender and the Law. Following her undergraduate studies, Gabrielle worked in public health communications in Dhaka, Bangladesh and helped administer direct services for pregnant women and families in Philadelphia.